e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(CSE:
MBIO
)
0.7700
-0.0300 (-3.75%)
Streaming Delayed Price
Updated: 12:51 PM EDT, May 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MBIO
< Previous
1
2
Next >
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Expands AI Voice Platform with Fatigue Detection Module
May 21, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
TechMediaBreaks – MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Advancing Workplace Safety with AI-Powered Technology
May 19, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
NetworkNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Featured in NetworkNewsAudio Editorial on Voice-Based Intoxication Detection
May 15, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) CEO Highlights AI Voice Detection Platform and Workplace Rollout Plans During TechMediaWire Podcast
May 15, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Cannabis
NetworkNews Audio Announces Audio Press Release (APR) Discussing Combining Artificial Intelligence with Speech Analysis to Detect Intoxication
May 15, 2026
From
NetworkNewsWire
Via
GlobeNewswire
NetworkNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Featured in BioMedWire Editorial on Real-Time Intoxication Detection Technologies
May 14, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Harnesses Key AI, Voice Analysis to Offer Impairment Solution
May 14, 2026
From
MindBio Therapeutics Corp.
Via
GlobeNewswire
Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities
May 13, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
TechMediaBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Spotlighted in BioMedWire Editorial on AI-Driven Impairment Detection
May 13, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities
May 13, 2026
From
BioMedWire
Via
GlobeNewswire
InvestorNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) CEO Featured on TechMediaWire Podcast Discussing AI Voice Detection Platform
May 12, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
BioMedNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Featured in BioMedWire Editorial on AI-Powered Intoxication Detection
May 12, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Leveraging AI, Voice Analysis to Develop Intoxication Detection
May 12, 2026
From
MindBio Therapeutics Corp.
Via
GlobeNewswire
NetworkNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Expands AI Voice Diagnostics Platform With Fatigue Detection Technology
May 11, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
TechMediaBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Advances AI Voice-Based Intoxication Detection as Real-Time Diagnostics Market Expands
May 11, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
The Future of Intoxication Detection May Be in Your Voice
May 11, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Files Patent Applications for Voice-Based Intoxication Detection
May 07, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
AINewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Develops Cross-Language AI Model For Intoxication Detection
May 05, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
NetworkNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Files Patent Applications for AI Voice Intoxication Detection Technology
April 29, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
The Future of Intoxication Detection May Be in Your Voice
May 11, 2026
From
BioMedWire
Via
GlobeNewswire
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Deploying AI for Non-Invasive Intoxication Detection
April 28, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
BioMedNewsBreaks — MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Advances Toward Commercial Deployment of AI Solution
April 24, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Broadens AI Intoxication Detection Platform with Launch of Intox Collect(TM)
April 20, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
BioMedNewsBreaks — MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Engages Venture Liquidity Providers for Market-Making Services
April 15, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Offers World’s First Voice-Enabled AI-Powered Drug and Alcohol Platform for Workplace Substance Abuse Screening
April 13, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
TechMediaBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Develops Intox Collect(TM) to Scale AI Voice-Based Intoxication Detection
April 13, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Targets South American Mining Sector as Voice-Based Drug and Alcohol Impairment Screening Platform Moves Toward Commercial Deployment
April 06, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Mindbio Announces Intention To Refile MD & A
February 14, 2025
Via
TheNewswire.com
Mindbio Announces Clinical Trial Milestone In Phase 2B Microdosing Trials Targeting Existential Distress, Depression & Anxiety In Advanced Stage Cancer
October 24, 2024
One of two Phase 2B trials currently dosing and underway:
Via
TheNewswire.com
MindBio Announces Sustained Antidepressant Response 3-Months Post Treatment in Microdosing Depression Clinical Trials
August 19, 2024
Via
ACCESSWIRE
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.